GeneDx Holdings Corp. (WGS) Earnings Per Share (EPS)
GeneDx Holdings Corp. (WGS) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2020-12-31 | -$47.04K |
| 2021-12-31 | -$74.91 |
| 2022-12-31 | -$53.79 |
| 2023-12-31 | -$7.23 |
| 2024-12-31 | -$1.94 |
| 2025-12-31 | -$0.73 |
How WGS compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc. | $1.21 |
| ARWR | Arrowhead Pharmaceuticals Inc. | -$0.01 |
| IMUX | Immunic Inc. | -$0.62 |
| IDYA | IDEAYA Biosciences Inc. | -$1.28 |
| HSDT | Helius Medical Technologies Inc. | -$1.85 |
These are five companies in the same sector as WGS with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get GeneDx Holdings Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("WGS")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | WGS | $81.74 | +4.96% | 0.65M |
| 3 | ||||
| 4 | ||||
| 5 |